Sign inJoin waitlistJoin the waitlist

Jose Karam

Professor · University of Texas M D Anderson Cancer Center

Credentials: · · · ·

History

University of Texas M D Anderson Cancer Center
Present

University of Texas M D Anderson Cancer Center
2010–2011
University of Texas M D Anderson Cancer Center
2009–2010
Urology
University of Texas Southwestern Medical Center
2005–2009
General Surgery
University of Texas Southwestern Medical Center
2004–2005
University of Texas Southwestern Medical Center
2003–2004
American University of Beirut
2002–2003
American Univ of Beirut, Beirut, Lebanon
1998–2002

Research

Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase…
Journal of Clinical Oncology · 2019 · 1,075 citations
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic…
The Lancet Oncology · 2016 · 930 citations
Epidemiology of Renal Cell Carcinoma: 2022 Update
Systematic review or meta-analysis · European Urology · 2022 · 648 citations

Surena Matin
82 papers
Nizar Tannir
61 papers
SS
Shahrokhf Shariat
39 papers
Pheroze Tamboli
38 papers
Eric Jonasch
35 papers
Vitaly Margulis
32 papers · 1 as a resident
Priya Rao
30 papers
Yair Lotan
28 papers
KS
Kanishka Sircar
27 papers
Pavlos Msaouel
26 papers · 18 as a fellow
CW
Christopher Wood
25 papers
Jay Raman
22 papers · 1 as a fellow

Clinical trials

Neoadjuvant Axitinib in Locally Advanced Renal Cell Carcinoma (RCC)
Principal investigator · Completed · Phase 2
M.D. Anderson Cancer Center
2011–2023